Superior Genomics, Inc.
PrivateLast Round
Seed
Aug 14, 2026
Total Funding Raised
$4,100
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Superior Genomics, Inc. is a health technology company that develops blood-based gene expression diagnostic tests for mental health disorders such as Major Depressive Disorder and Bipolar Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Superior Genomics, Inc. Comparables
Compare Superior Genomics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laguna Diagnostics, LLC | 85% | |
| MindX Sciences | 83% | |
| ALCEN | 82% |
Superior Genomics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 14, 2026 | ||||
| Grant | Dec 1, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2026
$508K raised in Seed Round.
- Dec 1, 2024
Received $4.1K grant from Central Upper Peninsula Small Business Support Hub.
Superior Genomics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Superior Genomics, Inc.'s valuation, stock price, and market status.
Is Superior Genomics, Inc. a public or private company?
Superior Genomics, Inc. is a private company.
What is the current stock price of Superior Genomics, Inc.?
Superior Genomics, Inc. is a private company with no public stock price. Caplight tracks Superior Genomics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Superior Genomics, Inc. worth (valuation)?
Valuation information for Superior Genomics, Inc. is not publicly available.
Can I buy Superior Genomics, Inc. stock?
Superior Genomics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Superior Genomics, Inc.'s last funding round?
Superior Genomics, Inc.'s most recent funding round was Seed Round on August 14, 2026.
Who are the main investors in Superior Genomics, Inc.?
Investor information for Superior Genomics, Inc. is not publicly disclosed.
Will Superior Genomics, Inc. IPO soon?
No public IPO plans have been announced for Superior Genomics, Inc..
How can I track Superior Genomics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Superior Genomics, Inc.'s secondary market activity and sign up for updates.